@article{bbbd63e1c0a240839e1f2788ccfa1adf,
title = "A phase III trial evaluating glofitamab in combination with gemcitabine plus oxaliplatin versus rituximab in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL)",
author = "Hertzberg, \{Mark S.\} and Matthew Ku and Olivier Catalani and Betsy Althaus and Steven Simko and Gregory, \{Gareth Peter\}",
note = "Poster Session Session Title: Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia Track: Hematologic Malignancies Sub Track: Hematologic Malignancies Abstract \# TPS7575; American Society of Clinical Oncology Annual Meeting 2021, ASCO 21 ; Conference date: 04-06-2021 Through 08-06-2021",
year = "2021",
month = may,
day = "28",
doi = "10.1200/JCO.2021.39.15\_suppl.TPS7575",
language = "English",
volume = "39",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology ",
number = "15 suppl",
}